SAN DIEGO — Two proposed new multiple myeloma staging systems offer similar prognostic accuracy compared with the standard staging system, but the new systems provide more refined risk classifications ...

Your survival rate for multiple myeloma is likely higher in earlier stages. Younger people often have better outcomes due to ...

Stage 2 multiple myeloma involves intermediate cancer levels, requiring treatment for symptoms like bone issues, anemia, and kidney problems. Diagnosis includes blood, urine, imaging tests, and ...

Researchers at The University of Texas MD Anderson Cancer Center have created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions. The ...

Using nationwide electronic health record (EHR) and cancer registry data from the VA Corporate Data Warehouse, we developed and validated a rule-based NLP algorithm to extract oncologist-determined MM ...

Staging is when a system is used to identify and describe how far a cancer has spread in your body. Knowing the stage of your multiple myeloma helps your physicians predict which treatments are most ...

Updated guidelines establish a dedicated framework for routine MRD assessment across the multiple myeloma patient journey ...

Staging, the process of finding out how advanced the cancer is, is very important because the treatment options and the outlook for recovery and survival depend on the stage of the cancer. Knowing all ...

The stage of diagnosis can impact survival rates. Patients with stage III multiple myeloma (MM) have an average life expectancy of 29 months, whereas patients with stages I and II disease survive on ...

Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group The clinical outcome of multiple myeloma (MM) is heterogeneous.